Weik Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,723
Closed -$461K 131
2017
Q4
$461K Hold
10,723
0.22% 83
2017
Q3
$534K Buy
10,723
+4,828
+82% +$234K 0.25% 81
2017
Q2
$282K Hold
5,895
0.15% 102
2017
Q1
$267K Buy
5,895
+50
+0.9% +$2.12K 0.14% 103
2016
Q4
$236K Buy
5,845
+350
+6% +$13.8K 0.13% 104
2016
Q3
$210K Buy
5,495
+200
+4% +$8.03K 0.12% 108
2016
Q2
$222K Buy
+5,295
New +$217K 0.13% 102
2016
Q1
Sell
-4,945
Closed -$211K 108
2015
Q4
$211K Buy
+4,945
New +$228K 0.13% 99

Other funds holding SNY

Weik Capital Management's SNY Position: Q1 2018 in Review

Weik Capital Management sold out of Sanofi (SNY) in Q1 2018, closing a stake of 10,723 shares — an estimated $461K sold.

Weik Capital Management first reported a position in SNY in Q4 2015 and held it in 8 quarters. The position peaked at $534K in Q3 2017. 487 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

  • Weik Capital Management reported no remaining Sanofi position as of Q1 2018 after selling out during the quarter.
  • Weik Capital Management sold 10,723 Sanofi shares in Q1 2018, an estimated $461K.
  • Weik Capital Management first reported a position in Sanofi in Q4 2015 and held it in 8 quarters.
  • Weik Capital Management's Sanofi position peaked at $534K in Q3 2017.
  • 487 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on Weik Capital Management's 13F filing for Q1 2018, filed 11 May 2018.